The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Cell-free DNA copy number variations as a marker for breast cancer in a large study cohort.
Julia Beck
Employment or Leadership Position - Chronix Biomedical
Stock Ownership - Chronix Biomedical
Ekkehard Schütz
Employment or Leadership Position - Chronix Biomedical
Stock Ownership - Chronix Biomedical
Howard B. Urnovitz
Employment or Leadership Position - Chronix Biomedical
Stock Ownership - Chronix Biomedical
Adel Tabchy
No relevant relationships to disclose
William M. Mitchell
Employment or Leadership Position - Chronix Biomedical (U)
Stock Ownership - Chronix Biomedical
Gordon B. Mills
No relevant relationships to disclose
Funda Meric-Bernstam
No relevant relationships to disclose